Psyllium (Plantago fiber)

What is psyllium and what does it do in the body?

According to MedlinePlus, psyllium is a bulk-forming laxative used to treat constipation; it absorbs fluid in the intestines, swells, and forms a bulky stool that is easy to pass. ^[1] In the US health claim on soluble fiber and coronary heart disease, 21 CFR 101.81 defines psyllium husk as a psyllium husk of at least 95% purity obtained from the dried husk (epidermis) of the seed of Plantago ovata (blond or Indian psyllium), P. indica, or P. psyllium. ^[11] This is “role in the body” information; how much benefit a fiber gives is measured by separate studies.

The definition of psyllium as a “gel-forming and non-fermented” fiber appears in the introduction of a review written by employees of a consumer products company; this information is the review’s introductory sentence, not a finding of the study. ^[9]

In what forms is psyllium found?

MedlinePlus states that psyllium is taken by mouth as powder, granules, capsules, liquid, and wafers. ^[1] The same source states that powders and granules must be mixed with 8 ounces (240 mL) of a flavored liquid immediately before use; that at least 240 mL of liquid must be drunk with each intake to be effective and to protect against side effects; and that it should not be used for longer than 1 week unless a physician says so. ^[1]

Does psyllium help constipation?

Yes; the evidence is moderate but heterogeneity is high.

The 2022 meta-analysis by van der Schoot and colleagues (16 RCTs, 1,251 adults; chronic constipation) found that the proportion responding to fiber supplementation was 311/473 (66%) versus 134/329 (41%) in the control group (RR 1.48; 95% CI 1.17–1.88; I² 57%). Psyllium and pectin showed a significant effect; response was evident only at high fiber doses such as >10 g/day. Stool frequency increased (SMD 0.72; 95% CI 0.36–1.08; I² 86%), stool consistency improved (SMD 0.32; 0.18–0.46); increased gas was reported (SMD 0.80; 0.47–1.13). The improvement in stool frequency was seen only at high doses and durations ≥4 weeks; the authors state that psyllium, >10 g/day, and a duration of at least 4 weeks appear to be the most suitable regimen, but that it should be interpreted with caution because of heterogeneity. ^[3]

The 2016 meta-analysis by Christodoulides and colleagues (7 RCTs; chronic idiopathic constipation) found that 113 of 147 people (77%) receiving fiber (including prebiotics) and 61 of 140 (44%) receiving placebo responded (RR 1.71; 95% CI 1.20–2.42). Stool frequency (SMD 0.39; 0.03–0.76) and consistency (SMD 0.35; 0.04–0.65) improved; gas also increased (SMD 0.56; 0.12–1.00). Evidence quality was low and risk of bias was high. ^[4]

In the 2021 exploratory, partially randomized study by Chey and colleagues (79 adults with chronic constipation; mean age 42.7; 87% women; ≤3 complete spontaneous bowel movements per week), green kiwifruit (2 per day), prunes (100 g per day), or psyllium (12 g per day) were given for 4 weeks; data were complete for 75 people. In the primary outcome, response rates were similar across the three treatments; weekly spontaneous bowel movements increased with all three (P ≤0.003); straining also decreased with psyllium (P=0.04); side effects were most common with psyllium. ^[7]

Does psyllium lower LDL cholesterol?

The meta-analysis by Jovanovski and colleagues covers 28 RCTs (n=1,924) lasting at least 3 weeks that examined psyllium’s effect on lipids in people with or without hypercholesterolemia. A median of about 10.2 g of psyllium lowered LDL cholesterol by −0.33 mmol/L (95% CI −0.38 to −0.27; P<0.00001; ≈12.8 mg/dL using the approximate factor of 38.67 to convert mmol/L to mg/dL), non-HDL cholesterol by −0.39 mmol/L (−0.50 to −0.27), and apolipoprotein B by −0.05 g/L (−0.08 to −0.03). The certainty of evidence was graded moderate for LDL and non-HDL because of inconsistency and high for apoB. ^[2] In the US, FDA’s 21 CFR 101.81 health claim lists psyllium husk among the accepted sources for soluble fiber and the risk of coronary heart disease. ^[11]

Does psyllium work in irritable bowel syndrome?

In the 2009 BMJ study by Bijkerk and colleagues (275 IBS patients in primary care, ages 18–65), 10 g of psyllium (n=85), 10 g of bran (n=97), or 10 g of placebo (rice flour; n=93) was given for 12 weeks. In the psyllium group the response rate was 57% versus 35% in the first month (RR 1.60; 95% CI 1.13–2.26) and 59% versus 41% in the second month (RR 1.44; 1.02–2.06); symptom severity fell by 90 points with psyllium and 49 points in the placebo group at the end of 3 months (P=0.03); bran was better than placebo only in the third month and its significance disappeared in the worst-case scenario analysis. There was no difference in quality of life. Of 85 people in the psyllium group, 54 (64%), in the bran group 54 (56%), and in the placebo group 56 (60%) completed the 3 months of treatment. ^[6]

The 2004 systematic review by Bijkerk and colleagues (17 studies; none in primary care IBS patients) reported that fiber overall benefited global symptoms in IBS (RR 1.33; 95% CI 1.19–1.50), might benefit patients with constipation-predominant IBS (RR 1.56; 1.21–2.02), but that there was no evidence that fiber was effective for abdominal pain. Soluble fiber (psyllium, ispaghula, calcium polycarbophil) showed significant benefit (RR 1.55; 1.35–1.78); insoluble fiber (corn, wheat bran) in some cases worsened the outcome and did not differ from placebo (RR 0.89; 0.72–1.11). The authors assessed the benefit of fiber in IBS as marginal for global symptoms and constipation. ^[5]

Does psyllium affect blood sugar and weight?

The 2015 meta-analysis by Gibb and colleagues (35 RCTs; 8 separate meta-analyses) found, in patients with type 2 diabetes, with psyllium given before meals in multi-week studies, a reduction of −37.0 mg/dL in fasting blood sugar (P<0.001) and −0.97% in HbA1c (−10.6 mmol/mol; P=0.048); the effect was proportional to baseline glucose, there was no significant decrease in euglycemic people, and a moderate improvement was seen in prediabetes. The authors stated that additional studies are needed to determine how to add psyllium to current treatment algorithms together with hypoglycemic drugs. Some of the authors are employees of a consumer products company, and the analysis also includes this company’s stored clinical records. ^[8]

The 2023 review by Gibb and colleagues (6 RCTs lasting ≥2 months in overweight and obese participants, total n=354; mean 10.8 g/day before meals, mean 4.8 months) found −2.1 kg for weight (95% CI −2.6 to −1.6), −0.8 kg/m² for BMI, and −2.2 cm for waist circumference (−2.9 to −1.4); according to the conflict-of-interest statement, the authors are employees of the same company that manufactures a product containing psyllium, and the number of studies is small. ^[9]

How should psyllium studies be read?

Three features limit the interpretation of psyllium studies. First, in the constipation meta-analyses, heterogeneity between studies is high (I² 86% for stool frequency; 57% for response rate), and fiber type, dose, and duration cannot be fully separated; besides psyllium, pectin also showed a significant effect. ^[3] Second, the older constipation analysis reports low evidence quality and high risk of bias. ^[4] Third, both analyses of the blood sugar and weight results were done by employees of the same company; this link does not show that the results are wrong, but it does not substitute for independent confirmation. ^{[8] [9]} In the IBS study, only 64% of the psyllium group completed the 3 months of treatment; this dropout rate limits the interpretation of the results. ^[6] In the cholesterol analysis, the effect comes from evaluating people with and without hypercholesterolemia together, and the certainty of evidence for LDL was graded moderate because of inconsistency. ^[2]

Is psyllium safe? Fluid, obstruction, allergy, and drug spacing

MedlinePlus states that people with allergies, people with bowel obstruction or difficulty swallowing, people with diabetes, heart disease, high blood pressure, kidney disease, and rectal bleeding, and those who are pregnant or breastfeeding should inform the physician; shortness of breath, stomach pain, difficulty swallowing, skin rash, itching, nausea, and vomiting are listed as signs of serious side effects. The same source says that the powder should not be inhaled while mixing (if accidentally inhaled it can cause an allergic reaction) and that digoxin, salicylate (aspirin), and nitrofurantoin should not be taken within 3 hours after psyllium intake. ^[1]

Khalili and colleagues reported a case of fatal anaphylaxis in a 42-year-old woman after swallowing a product containing psyllium; according to the review, psyllium hypersensitivity is well described in health care workers and pharmaceutical factory workers, symptoms range from upper respiratory symptoms when inhaled to anaphylaxis when swallowed, and there is a clear association between atopy and psyllium allergy. ^[10] Increased gas (SMD 0.56–0.80) is a side effect reported in the constipation meta-analyses. ^{[3] [4]}

How is psyllium regulated in Türkiye?

In Türkiye, food supplements are regulated by the Ministry of Agriculture and Forestry, and Ministry approval is mandatory for every food supplement to be placed on the market. ^[14] Two Ministry lists relate to psyllium:

• Plant List (updated July 16, 2026): Plantago ovata (synonym P. ispagula; “Karnıyarık otu” [Plantago], part used: seed husk) is positive (P) at serial number 460; Plantago psyllium (synonyms P. afra, P. indica; “Karnıyarık otu” [Plantago], seed) is positive (P) at serial number 461. ^[12]
• Restricted Substances List (last updated September 21, 2026): There is no separate active-substance row for psyllium; in the “Lif” (Fiber; “cereal fiber, fruit fiber, etc. listed as positive in the Plant List”) row, Plantago (Plantago ovata) is named among the sources; the 11 years and older column has a “-” sign (according to the list’s explanation: evaluated by the Ministry but no upper limit has been set); the ages 4–10 columns are empty; the publication date is April 28, 2017. ^[13]

In this case, there is no upper limit in mg for psyllium as a fiber source in the list; the amounts of 10 g/day and above used in studies therefore cannot be compared with the list limit. This guide does not recommend doses.

Evidence table: claim, population, and limits